PDF Download
ACRP CCRC EXAM QUESTIONS
Actual Qs and Ans - Expert-Verified Explanation -Guaranteed passing score -100 Questions and Answers
-Format: Multiple-choice / Flashcard
Question 1: Advocate
Answer:
Is a witness assigned as a monitor to attest to consenting process
Question 2: Required essential documents provided during study
Answer:
*updates to IB *updates to protocol / CRF, etc *approvals from IRB of updated materials *updates to any procedures / tests / shipping *records of any monitoring visits *signed ICF *completed CRFs, signed & dated *documentation of edited CRFs *source docs for completing CRFs *documentation of AEs/SAEs *subjects screening log *Subject enrollment log *subject ID code list
- investigational product accountability
*signature sheet (KSP) *record of samples
Question 3: Requirements of an IRB
Answer:
- at least 5 members
- one non-scientific member
- one non-institute member
Question 4: IEC
Answer:
Independent Ethics Committee; group who oversees protection, rights, safety & well-being of human subjects
Question 5: Reporting time frame for events
Answer:
Fatal/Life threatening unexpected = ASAP; no more than 7 days after event Non fatal/Life threatening = 15 days *ok if not all info is available --> submit what you have
Question 6: If unblinding occurs who reports & to whom?
Answer:
PI to sponsor only
Question 7: Consenting illiterate subjects
Answer:
is okay, but must have impartial witness present
Question 8: Peak
Answer:
Varies, but usually around 30 mins to several hours after dosing, depends on administration
Question 9: Who has responsibility for investigational product accountability?
Answer:
PI/Site
Question 10: Double Blind Study
Answer:
Subjects & Researchers are unaware
Question 11: Pre-Clinical Trials
Answer:
Animal/Translational Research - 4.5 years
Question 12: Legally acceptable representative
Answer:
person whom is lawfully able to consent on behalf of another
Question 13: Auditors vs Monitors vs inspectors
Answer:
*Monitors - address data, storage of drug, & report to sponsor/investigator. They can be internal *Auditors - focused on compliance which is separate from routine monitoring - they should not be part of trial; independent committee reviewing data *Inspectors - IRB or regulatory body reviewing data
Question 14: Monitors & Auditors differ in what major way?
Answer:
monitors are supplied by sponsor as part of sponsor team. Auditors are independent.
Question 15: IDMC
Answer:
Independent Data Monitoring Committee, Data & Safety Monitoring Board (DSMB), Data Monitoring Committee: Oversee safety & progress; make recommendations to continue, modify or stop
Question 16: Parallel Trial Design
Answer:
Study Group ----------------> END Control Group --------------> END
Question 17: Purpose of Trial monitoring
Answer:
*Ensure rights & safety of subjects are protected *Report on accuracy of trial data *Ensure trial is compliant (protocol, GCP, etc) Question 18: Does the PI need to notify sponsor of administrative changes to protocol, ICF, etc
Answer:
No
Question 19: an adverse drug reaction requires what level of causality?
Answer:
reasonable possibility
Question 20: Crossover Trial Design
Answer:
Study Group ----------> Control Group ------> END Control Group --------> Study Group ------> END *main issue is ample wash out time b/w crossovers
Question 21: LFTs
Answer:
Liver Function Tests Total Protein Albumin Bilirubin ALP (Alk Phos)
AST/ALT
Question 22: Single Blind Study
Answer:
Subjects Unaware Question 23: Other serious, but non-fatal / life-threatening ADRs should be reported in what time frame?
Answer:
ASAP, no more than 15 days